Seagen Inc. Share Price and Company Fundamentals



Price
$170.14
Change
-3.900 (-2.241%)
52 week
105.43 - 192.79

Last traded: Last Friday at 8:00 PM

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Key Metrics

PE ratio

-

PB ratio

10.70

Dividend yield

0.00%

Beta

0.57

Market cap

-

Enterprise value

-

Company profile

Industry / SectorBiotechnology / Healthcare
Full time employees2675
Websitehttps://www.seagen.com
Mailing address21823 30th Drive SE Bothell WA 98021 United States
Phone / Fax425 527 4000 /

Dividends

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Seagen Inc. paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SGEN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

SGEN's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Seagen Inc..

NameTitleAgeTotal Pay
Dr. Roger D. Dansey M.D.Chief Medical Officer & Interim CEO651.53M
Dr. Clay B. Siegall Ph.D.Co-Founder, Chairman, Pres & CEO (Leave of Absence)603.09M
Mr. Todd E. SimpsonChief Financial Officer601.17M
Ms. Jean I. Liu J.D., M.S.Chief Legal Officer531.11M
Mr. Charles R. RompExec. VP of Commercial U.S.531.02M
Dr. Vaughn B. Himes Ph.D.Chief Technical Officer60
Peggy PinkstonSr. VP of Investor Relations
Mr. David CaouetteVP of Corp. Communications
Ms. Natasha A. HerndayExec. VP of Corp. Devel. & Alliance Management49
Mr. Matt SkeltonVP of Marketing

Profitability and management effectiveness

Profit margin

-41.61%

Operating margin

-41.41%

Return on assets

-12.14%

Return on equity

-23.40%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Seagen Inc. is and its enterprise value is .

The SGEN's stocks Beta value is 0.57 making it 43% less volatile compared to NASDAQ market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Seagen Inc. (NASDAQ:SGEN) Frequently Asked Questions

1. What is Seagen Inc.'s Stock Symbol?

Seagen Inc. trades on NASDAQ under the ticker symbol "SGEN".

2. What is Seagen Inc.'s stock price today?

One share of SGEN stock can currently be purchased for approximately $170.14.

3. How can I contact Seagen Inc.?

Seagen Inc.'s mailing address is 21823 30th Drive SE Bothell WA 98021 United States. The company can be reached via phone at 425 527 4000.

4. What is Seagen Inc.'s official website?

The official website of Seagen Inc. is https://www.seagen.com.